ZHCLF (ZHCLF) Stock Price & Analysis
ZHCLF (ZHCLF) rose 0.00% to USD 0.05 as of July 25, 2026 at 06:10 UTC, according to Nexqual real-time market data.
ZHCLF last closed at USD 0.05; the session ranged USD 0.05–0.05 on volume of 2,101 shares. Market capitalization is $7.99M, with a 52-week range of USD 0–0.19 (PNK). Source: Nexqual, July 25, 2026 at 06:10 UTC.
Key Statistics (as of July 25, 2026 at 06:10 UTC)
| Price | USD 0.05 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.05 |
| Open | USD 0.05 |
| Day Range | USD 0.05 – 0.05 |
| 52-Week Range | USD 0 – 0.19 |
| Volume | 2,101 shares |
| Market Cap | $7.99M |
| Exchange | PNK |
Technical Analysis (ZHCLF)
Nexqual's technical model rates ZHCLF "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of July 25, 2026 at 06:10 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 44.3 (neutral) |
| vs SMA50 | Below (USD 0.06) |
| MACD | -0 (negative) |
Analyst Ratings (ZHCLF)
Wall Street analysts rate ZHCLF "None", per Nexqual as of July 25, 2026 at 06:10 UTC.
| Consensus Rating | None |
|---|
Earnings (ZHCLF)
Source: Nexqual, July 25, 2026 at 06:10 UTC.
Financials & Fundamentals (ZHCLF)
| Total Revenue | $500,000 |
|---|---|
| Gross Margin | +100.00% |
| Operating Margin | -665.80% |
| Profit Margin | +0.00% |
| Current Ratio | 0 |
| Total Cash | $22,000 |
| Total Debt | $20.87M |
| Free Cash Flow | $8.92M |
Source: Nexqual, July 25, 2026 at 06:10 UTC.
Financial Health Score (ZHCLF)
Nexqual rates ZHCLF's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 06:10 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $22K cash vs $21M debt |
| Cash Flow | Strong — FCF $9M, 1783% margin |
| Efficiency | Mixed — No data |
Ownership (ZHCLF)
| Shares Outstanding | 159.73M |
|---|---|
| Float | 155.23M |
Source: Nexqual, July 25, 2026 at 06:10 UTC.
Leadership (ZHCLF)
ZHCLF is led by Donald J. McCaffrey, Chairman, President & CEO, per Nexqual as of July 25, 2026 at 06:10 UTC.
| Chairman, President & CEO | Donald J. McCaffrey |
|---|---|
| CFO & Secretary | Aaron Bradley Cann C.A., CPA, CBV |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BIOAF | BIOASIS TECHNOLOGIES INC | USD 0 | ▲ 0% |
| BETRF | BETTERLIFE PHARMA INC. | USD 0.15 | ▼ 13.45% |
| INNMF | Amplia Therapeutics Ltd. | USD 0.11 | ▲ 0% |
| SYGGF | SYNAIRGEN | USD 0 | ▲ 0% |
| PKTX | ProtoKinetix, Inc. | USD 0.01 | ▲ 3.12% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 06:10 UTC. This page is informational and not investment advice.